26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket trans...
Read More >
Selling your company for a huge profit sounds enticing. What could be wrong with getting a huge up-f...
Read More >
H-1B visa petitions have been receiving increased denials from the US Citizenship & Immigration Serv...
Read More >
On June 11, 2019, Gov. Gretchen Whitmer enacted a significant new Michigan mini tort law change when...
Read More >
The lowered threshold for foreign direct investments into France will apply to non-EU and non-EEA in...
Read More >
On August 6, 2019, Acting Governor Sheila Oliver signed S1790 into law (“Law”), toughening the pen...
Read More >